Medsafe Approves Trientine Tetrahydrochloride (Cuprior) for the Treatment Of Wilson's Disease
Te Arai BioFarma are happy to announce that Medsafe has approved an innovative new treatment for Wilson's Disease, trientine...
top of page
NEWS
Oct 30, 2020
PHARMAC funds new medicine MacroBID®
PHARMAC today announced their decision to fund MacroBID® modified release nitrofurantoin capsules. MacroBID® is a modified release...
Oct 1, 2020
New Antibiotic registered to treat Urinary Tract Infections (UTI)
MacroBID® is a new antibiotic medicine Medsafe registered by Te Arai BioFarma. MacroBID® is a modified release nitrofurantoin containing...
bottom of page